XELOX Plus Apatinib vs XELOX as Post-operative Chemotherapy in Locally Advanced Gastric Signet Ring Carcinoma

NCT03355612 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

456

Enrollment

OTHER

Sponsor class

Conditions

Gastric Carcinoma

Interventions

DRUG: Apatinib
DRUG: XELOX

Sponsor

Tianjin Medical University Cancer Institute and Hospital